A Potential Role for Alterations of Zinc and Zinc Transport Proteins in the Progression of Alzheimer's Disease
Open accessThe DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.
Abstract
Although multiple studies have suggested a role for alterations of zinc (Zn) and zinc transport (ZnT) proteins in the pathogenesis of Alzheimer's disease, the exact role of this essential trace element in the progression of the disease remains unclear. The following review discusses the normal role of Zn and ZnT proteins in brain and the potential effects of their alteration in the pathogenesis of Alzheimer's disease, particularly in the processing of the amyloid-beta protein precursor and amyloid-beta peptide generation and aggregation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Lovell (93) reported that AB/Zn ratios 1:0.1 and 1:0.01 result in a protective activity against AB toxicity.”
From Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease (2013) · cites this paper as [93]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · cited 1×
“…[9,10], single nucleotide polymorphisms in the gene that codes for ubiquilin-1 [11], a genetic locus on chromosome 10 that includes the insulin-degrading enzyme [12–14] that may interact with and degrade A β , inherited variants in SORL1 [15], and the presence of apolipoprotein E4 alleles [16].”
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762 · cited 1×
“…etiologic/pathogenic mechanisms have been suggested for the cause of AD including genetic defects [10,30], the amyloid cascade hypothesis (reviewed in [31]), trace element toxicity (reviewed in [32]), the oxidative stress hypothesis [33], mitochondrial defects [34], or a combination of the above.”
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237 · cited 1×
“], hyperlipidemia [23], hypertension [24], heart disease [25], smoking [26,27], elevated plasma homo-cysteine [28], and obesity [29].”
The biochemical basis of zinc physiology
Vallee, B. L., & Falchuk, K. H. (1993) · Physiological Reviews · doi:10.1152/physrev.1993.73.1.79 · Cited by 2,990 · cited 1×
“Zn is an essential trace element [35] that is redox-inert with structural,catalytic, and regulatory roles [36– 38].”
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577 · cited 1×
“…identified for AD include age [2], genet-ic factors including presenilin 1 (PS1) and 2 (PS2) and amyloid-β protein precursor (A β PP) mutations [9,10], single nucleotide polymorphisms in the gene that codes for ubiquilin-1 [11], a genetic locus on chromosome 10 that includes the…”
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168 · cited 2×
“Without preventive strategies, there may be 14 million Americans with AD by the year 2040 [1].”
Influential
Research works printed but not linked: 5
- [80]Golden BE Mills CF Zinc in cell division and tissue growth: Physiological aspects Zinc in Human Biology Springer-Verlag London 1989 119 127
- [135]Markesbery WR Ehmann WD Terry RD Katzman R Trace element alterations in Alzheimer’s disease Alzheimer’s disease Raven Press New York 1994
- [156]Petersen RC Morris JC Petersen RC Clinical features Mild Cognitive Impairment Oxford University New York 2003 15 39
- [180]St George-Hyslop PH Terry RD Katzman R Bick LL The molecular genetics of Alzheimer’s disease Alzheimer’s disease Raven Press New York 1994 345 352
- [196]Williams RJP Mills CF An introduction to the biochemistry of zinc Zinc in Human Biology Springer-Verlag London 1989 15 31
Cited by
Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease
Prasad, A. S. (2013) · Advances in Nutrition · doi:10.3945/an.112.003210 · Cited by 919
“Lovell (93) reported that AB/Zn ratios 1:0.”
Zinc in the physiology and pathology of the CNS
Sensi, S. L., Paoletti, P., Bush, A. I., & Sekler, I. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2734 · Cited by 759
Bioinorganic Chemistry of Alzheimer’s Disease
Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 672
Copper, zinc and iron in neurodegenerative diseases (Alzheimer's, Parkinson's and prion diseases)
Kozlowski, H., Luczkowski, M., Remelli, M., & Valensin, D. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.013 · Cited by 437
Plasma nutrient status of patients with Alzheimer's disease: Systematic review and meta‐analysis
Lopes da Silva, S., Vellas, B., Elemans, S., Luchsinger, J., Kamphuis, P., Yaffe, K., Sijben, J., Groenendijk, M., & Stijnen, T. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.05.1771 · Cited by 311
“Zinc and calcium share many transport and signaling pathways [80] and have been implicated in the disease process [81].”
Zinc homeostasis and neurodegenerative disorders
Szewczyk, B. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00033 · Cited by 288
“…of subjects diagnosed with the preclinical stage of AD (PCAD), mild cognitive impairment (MCI), early (EAD), and the late (LAD) stage of AD when compared to the control subjects (Lovell et al., 2005, 2006; Smith et al., 2006; Lovell, 2009; Lyubartseva et al., 2010; Lyubartseva and Lovell, 2012).”
ResultHosseini, S., Wilk, E., Michaelsen-Preusse, K., Gerhauser, I., Baumgärtner, W., Geffers, R., Schughart, K., & Korte, M. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.1740-17.2018 · Cited by 236
Microglia and Alzheimer’s Disease
Merighi, S., Nigro, M., Travagli, A., & Gessi, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112990 · Cited by 236
Genome-wide association study identifies loci affecting blood copper, selenium and zinc
Evans, D. M., Zhu, G., Dy, V., Heath, A. C., Madden, P. A. F., Kemp, J. P., McMahon, G., St Pourcain, B., Timpson, N. J., Golding, J., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt239 · Cited by 225
“There is evidence for Zn affecting the processing and aggregation of amyloid precursor protein (28,29).”
BackgroundZinc in the central nervous system: From molecules to behavior
Gower‐Winter, S. D., & Levenson, C. W. (2012) · BioFactors · doi:10.1002/biof.1012 · Cited by 206
“Among the many factors involved in the pathology of AD, dyshomeostasis of trace metals, including zinc, copper, and iron, has been suggested as a potential, albeit controversial, culprit [39].”
BackgroundSoil Contamination, Nutritive Value, and Human Health Risk Assessment of Heavy Metals: An Overview
Oves, M., Khan, M. S., Zaidi, A., & Ahmad, E. (2012) · Toxicity of Heavy Metals to Legumes and Bioremediation · doi:10.1007/978-3-7091-0730-0_1 · Cited by 178
Copper in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies
Bucossi, S., Ventriglia, M., Panetta, V., Salustri, C., Pasqualetti, P., Mariani, S., Siotto, M., Rossini, P. M., & Squitti, R. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101473 · Cited by 182
Therapeutic targets in age-related macular disease
Bird, A. C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42437 · Cited by 175
The Important Role of Zinc in Neurological Diseases
Li, Z., Liu, Y., Wei, R., Yong, V. W., & Xue, M. (2022) · Biomolecules · doi:10.3390/biom13010028 · Cited by 192
Metal Ion Physiopathology in Neurodegenerative Disorders
Bolognin, S., Messori, L., & Zatta, P. F. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8102-1 · Cited by 169
The Role of Zinc in Alzheimer′s Disease
Watt, N. T., Whitehouse, I. J., & Hooper, N. M. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/971021 · Cited by 148
“An increase in ZnT6 would lead to an increase in zinc in the TGN [108] which could reduce α-secretase activity [83].”
BackgroundZinc in the Brain: Friend or Foe?
Choi, S., Hong, D. K., Choi, B. Y., & Suh, S. W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238941 · Cited by 147
Zinc: A Necessary Ion for Mammalian Sperm Fertilization Competency
Kerns, K. C., Zigo, M., & Šutovský, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124097 · Cited by 138
Migliorini, C., Porciatti, E., Łuczkowski, M., & Valensin, D. (2011) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2011.07.004 · Cited by 122
Chen, Y., Qian, X., Zhang, Y., Su, W., Huang, Y., Wang, X., Chen, X., Zhao, E., Han, L., & Ma, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.840386 · Cited by 133
“Approximately 80% of MCI patients will have converted to AD (Tábuas-Pereira et al., 2016), although some patients with MCI remain stable or convert back to normal (Lovell, 2009).”
AMPA Receptors as Therapeutic Targets for Neurological Disorders
Lee, K., Goodman, L., Fourie, C., Schenk, S., Leitch, B., & Montgomery, J. M. (2015) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2015.10.004 · Cited by 122
Bjorklund, N. L., Reese, L. C., Sadagoparamanujam, V.-M., Ghirardi, V., Woltjer, R. L., & Taglialatela, G. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-23 · Cited by 98
“Zn, a transition metal dysregulated in AD [23,24], has been shown to stabilize Aβ oligomers [25] and target them to the postsynapse [26].”
Zeng, G.-F., Zhang, Z.-Y., Lu, L., Xiao, D.-Q., Zong, S.-H., & He, J.-M. (2013) · Rejuvenation Research · doi:10.1089/rej.2012.1389 · Cited by 94
“22 The exact mechanism of damage in AD is still hotly debated among medical professionals.”
Zinc in Alzheimer’s Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies
Ventriglia, M., Brewer, G. J., Simonelli, I., Mariani, S., Siotto, M., Bucossi, S., & Squitti, R. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-141296 · Cited by 94
“Zinc is necessary for brain development and physiology zinc deficiency, such as learning, memory, and emotional stability, relate to functions of brain structures normally rich in this metal, such as hippocampus amygdala, and neocortex [2].”
Surface Functionalized Selenium Nanoparticles for Biomedical Applications
Chaudhary, S., Umar, A., & Mehta, S. K. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2014.1985 · Cited by 97
Multifunctional roles of zinc in Alzheimer’s disease
Xie, Z., Wu, H., & Zhao, J. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.07.003 · Cited by 89
Shigemizu, D., Akiyama, S., Higaki, S., Sugimoto, T., Sakurai, T., Boroevich, K. A., Sharma, A., Tsunoda, T., Ochiya, T., Niida, S., et al. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00716-0 · Cited by 74
“After 6 years of follow-up, approximately 80% of MCI patients will have converted to AD (MCI converters [MCI-C]) [4, 5], although some MCI patients remain stable or convert back to normal (MCI non-converters [MCI-NC]) [6].”
BackgroundCamponeschi, F., Valensin, D., Tessari, I., Bubacco, L., Dell’Acqua, S., Casella, L., Monzani, E., Gaggelli, E., & Valensin, G. (2013) · Inorganic Chemistry · doi:10.1021/ic302050m · Cited by 71
ZIP4 is a novel molecular marker for glioma
Lin, Y.-K., Chen, Y., Wang, Y., Yang, J., Zhu, V. F., Liu, Y., Cui, X., Chen, L., Yan, W., Jiang, T., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not042 · Cited by 64
The Multifaceted Roles of Zinc in Neuronal Mitochondrial Dysfunction
Liu, H. Y., Gale, J. R., Reynolds, I. J., Weiss, J. H., & Aizenman, E. (2021) · Biomedicines · doi:10.3390/biomedicines9050489 · Cited by 75
AlMohimeed, A., Saad, R. M. A., Mostafa, S., El-Rashidy, N. M., Farrag, S., Gaballah, A., Elaziz, M. A., El–Sappagh, S., & Saleh, H. (2023) · IEEE Access · doi:10.1109/access.2023.3328331 · Cited by 81
“However, some MCI patients, referred to as stable MCI (sMCI), either remain stable or even revert to normal [9].”
Importance and management of micronutrient deficiencies in patients with Alzheimer’s disease
Cardoso, B., Cominetti, & Cozzolino (2013) · Clinical Interventions in Aging · doi:10.2147/cia.s27983 · Cited by 62
“70 Processing by the nonamyloidogenic pathway, which is catalyzed by one alpha-secretase and results in the formation of soluble APP, a neurotrophic factor, 71 may be influenced by Zn because APP presents a binding site for this metal at the position where alpha-secretase catalyzes the processing…”
Zinc diet and Alzheimer's disease: a systematic review
Loef, M., von Stillfried, N., & Walach, H. (2012) · Nutritional Neuroscience · doi:10.1179/1476830512y.0000000010 · Cited by 56
Zinc Transporter mRNA Levels in Alzheimer's Disease Postmortem Brain
Beyer, N., Coulson, D. T. R., Heggarty, S., Ravid, R., Hellemans, J., Irvine, G. B., & Johnston, J. A. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-112105 · Cited by 53
“concentrations are maintained in each compartment, in addition to the buffering activities of metallothionein proteins (see [14] and references therein).”
Zinc Therapy in Early Alzheimer’s Disease: Safety and Potential Therapeutic Efficacy
Squitti, R., Pal, A., Picozza, M., Avan, A., Ventriglia, M., Rongioletti, M. C. A., & Hoogenraad, T. U. (2020) · Biomolecules · doi:10.3390/biom10081164 · Cited by 54
“The mechanisms by which zinc exerts its toxicity during ischemic insults seems to be ascribable to structural abnormalities in tubulin or microtubule associated proteins assembly [43].”
BackgroundTautomeric Effect of Histidine on the Monomeric Structure of Amyloid β-Peptide(1–40)
Shi, H., Kang, B., & Lee, J. Y. (2016) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.6b08685 · Cited by 47
Iron in Alzheimer’s Disease: From Physiology to Disease Disabilities
Pal, A., Cerchiaro, G., Rani, I., Ventriglia, M., Rongioletti, M. C. A., Longobardi, A., & Squitti, R. (2022) · Biomolecules · doi:10.3390/biom12091248 · Cited by 53
Górska, A., Markiewicz-Gospodarek, A., Markiewicz, R., Chilimoniuk, Z., Borowski, B., Trubalski, M., & Czarnek, K. (2023) · Brain Sciences · doi:10.3390/brainsci13060911 · Cited by 49
Fenech, M. F. (2013) · Cancer treatment and research · doi:10.1007/978-3-642-38007-5_24 · Cited by 47
Synergistic accumulation of iron and zinc by cultured astrocytes
Bishop, G. M., Scheiber, I. F., Dringen, R., & Robinson, S. R. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0420-9 · Cited by 43
Ricco, R. D., Valensin, D., Dell’Acqua, S., Casella, L., Dorlet, P., Faller, P., & Hureau, C. (2015) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.5b00120 · Cited by 43
β‐Amyloid pathogenesis: Chemical properties versus cellular levels
Tiwari, M. K., & Kepp, K. P. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.06.1895 · Cited by 37
“subsequent cleavage by the enzyme complex g-secretase at multiple sites lead to formation of several Ab isoforms [56] (only Ab42 is shown for clarity).”
BackgroundDifferences in the Binding of Copper(I) to α- and β-Synuclein
Ricco, R. D., Valensin, D., Dell’Acqua, S., Casella, L., Gaggelli, E., Valensin, G., Bubacco, L., & Mangani, S. (2014) · Inorganic Chemistry · doi:10.1021/ic502407w · Cited by 39
The Efficacy and Pharmacological Mechanism of Zn7MT3 to Protect against Alzheimer’s Disease
Xu, W., Xu, Q., Cheng, H., & Tan, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-12800-x · Cited by 39
Fenech, M. F. (2010) · Genome Integrity · doi:10.1186/2041-9414-1-11 · Cited by 37
“Dietary profile differs between individuals to varying extents depending on their acquired or inherited dietary preferences and food availability; furthermore uptake of micronutrients from the digestive system and transport into cells of the body also varies depending on genetics and altered expression of transporters…”
BackgroundBjorklund, N. L., Sadagoparamanujam, V.-M., & Taglialatela, G. (2012) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.09.008 · Cited by 34
Zinc signaling through glucocorticoid and glutamate signaling in stressful circumstances
Takeda, A., & Tamano, H. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22456 · Cited by 34
Is there a role for Mycobacterium avium subspecies paratuberculosis in Parkinson's disease?
Arru, G., Caggiu, E., Paulus, K. S., Sechi, G., Mameli, G., & Sechi, L. A. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.02.016 · Cited by 38
“In addition, the role of ZnT family proteins in Parkinson and Alzheimer's diseases is well documented (Prakash et al., 2015, Szewczyk, 2013; Lovell, 2009, Yokel, 2006).”
A potential role for zinc alterations in the pathogenesis of Alzheimer's disease
Lyubartseva, G., & Lovell, M. A. (2012) · BioFactors · doi:10.1002/biof.199 · Cited by 33
Self-citationWhat Are the Functions of Zinc in the Nervous System?
Benarroch, E. E. (2023) · Neurology · doi:10.1212/wnl.0000000000207912 · Cited by 31
“Zinc has also been associated with mechanisms of Alzheimer disease.(129) In this disorder, there are increased Zn levels in the cortex altered expression of different ZnT transporters either at or surrounding senile plaques.”
BackgroundElbadawy, H. A., El‐Dissouky, A., Elkashef, A. A., Foro, S., & El‐Sayed, D. S. (2022) · Applied Organometallic Chemistry · doi:10.1002/aoc.6793 · Cited by 27
Feng, C., Liu, Y., Yuan, Y., Cui, W., Zheng, F., Ma, Y., & Piao, M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.08.035 · Cited by 29
Ma, F., Wang, H., Chen, B., Wang, F., & Xu, H. (2011) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2011000100020 · Cited by 25
Sandusky‐Beltran, L. A., Manchester, B. L., & McNay, E. C. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.07.007 · Cited by 26
Peroxidase activity of heme bound amyloid β peptides associated with Alzheimer's disease
Roy, M., Pal, I., Nath, A. K., & Dey, S. G. (2020) · Chemical Communications · doi:10.1039/c9cc09758a · Cited by 27
Saleh, H., El-Rashidy, N. M., Elaziz, M. A., Aseeri, A. O., & El–Sappagh, S. (2024) · International Journal of Data Science and Analytics · doi:10.1007/s41060-024-00514-z · Cited by 30
Zinc in Regulating Protein Kinases and Phosphatases in Neurodegenerative Diseases
Zhang, H.-L., Wang, X., & Liu, R. (2022) · Biomolecules · doi:10.3390/biom12060785 · Cited by 21
Chen, A., Gao, G., Lian, G., Gong, J., Luo, L., Liu, J., Chen, W., Xu, C., Wang, H., & Xie, L. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2205209 · Cited by 21
“Excessive cytoplasmic zinc has been demonstrated to contribute to tumorigenesis [8], neurological disorders [9], PAH [10], male reproductive disorders, and cardiovascular diseases [11].”
Metal Binding to Amyloid-β1–42: A Ligand Field Molecular Dynamics Study
Mutter, S. T., Turner, M., Deeth, R. J., & Platts, J. A. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00210 · Cited by 24
Rocchi, A., Valensin, D., Aldinucci, C., Giani, G., Barbucci, R., Gaggelli, E., Kozłowski, H., & Valensin, G. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.08.021 · Cited by 20
Early and Late Pathomechanisms in Alzheimer’s Disease: From Zinc to Amyloid-β Neurotoxicity
Szutowicz, A., Bielarczyk, H., Zyśk, M., Dyś, A., Ronowska, A., Gul‐Hinc, S., & Klimaszewska‐Łata, J. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2154-z · Cited by 17
Shigemizu, D., Akiyama, S., Mitsumori, R., Niida, S., & Ozaki, K. (2022) · npj Aging · doi:10.1038/s41514-022-00096-9 · Cited by 16
The effect of zinc supplementation on brain derived neurotrophic factor: A meta-analysis
Jafari, F., Mohammadi, H., & Amani, R. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126753 · Cited by 19
Multifunctional fluorescence sensor as a potential theranostic agent against Alzheimer's disease
Kou, X., Li, X., Hu, C., Liu, J., Chen, Y., Zhang, Y., Yang, A., & Shen, R. (2021) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2021.120587 · Cited by 13
Zyśk, M., Bielarczyk, H., Gul‐Hinc, S., Dyś, A., Gapys, B., Ronowska, A., Sakowicz‐Burkiewicz, M., & Szutowicz, A. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160693 · Cited by 14
Biometals and Alzheimer’s Disease
Mot, A. I., & Crouch, P. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804562-6.00001-4 · Cited by 16
Zinc mediates the neuronal activity–dependent anti-apoptotic effect
Qiu, M., Shentu, Y., Zeng, J., Wang, X., Yan, X., Zhou, X., Jing, X., Wang, Q., Man, H., Wang, J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182150 · Cited by 11
Molecular dynamics simulations of copper binding to amyloid-β Glu22 mutants
Mutter, S. T., Turner, M., Deeth, R. J., & Platts, J. A. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e03071 · Cited by 10
“This is an open access a The role of metal ions in AD is increasingly recognised, as disease progression correlates with the breakdown in homeostasis of copper, iron and zinc in the brain [12, 13, 14, 15, 16].”
BackgroundPlatts, J. A. (2020) · Royal Society Open Science · doi:10.1098/rsos.191562 · Cited by 11
SCREEN PRINTED ELECTRODES USED FOR DETECTION OF IONIC HEAVY METALS
Florescu, M., Badea, M., Coman, G., Marty, J., & Mitrică, M. (2009) · Bulletin of the Transilvania University of Brasov Series VI Medical Sciences · Cited by 10
Salem, H., Suchting, R., Gonzales, M. M., Seshadri, S. S., & Teixeira, A. L. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220826 · Cited by 13
Biomarkers and Their Implications in Alzheimer’s Disease: A Literature Review
Marcucci, V., & Kleiman, J. (2021) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2021.00016 · Cited by 9
Metals in Cells: Control of Cellular Metal Concentration
Gilston, B. A., & O’Halloran, T. V. (2004) · Wiley eBooks · doi:10.1002/9781119951438.eibc2107 · Cited by 7
Pathogenetic Mechanisms in Age-Related Macular Degeneration
Bird, A. C. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0737-9.00064-3 · Cited by 7
A Review on the Pathophysiology of Alzheimer’s Disease
Agarwal, U., Kapoor, G. T., & Tonk, R. K. (2025) · Current Protein and Peptide Science · doi:10.2174/0113892037416859250915091846 · Cited by 5
Zinc in Alzheimer’s and Parkinson’s Diseases
Ayton, S., Finkelstein, D. I., Cherny, R. A., Bush, A. I., & Adlard, P. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-1533-6_214 · Cited by 5
Ghamsary, M. S., Ghiasi, M., & Naghavi, S. S. (2024) · Physical Chemistry Chemical Physics · doi:10.1039/d3cp05687b · Cited by 3
Biomarkers of Alzheimer's Disease: A Review
Mohapatra, D., Jena, S. R., Prusty, S. K., & Sahu, P. K. (2020) · Systematic Reviews in Pharmacy · Cited by 3
Xi, J., He, K., Hou, L., Smets, B., Miller, S., Saad, Z. S., Whelan, C. D., Ruiz, A., Puerta, R., Cano, A. C., et al. (2026) · npj Dementia · doi:10.1038/s44400-025-00053-9 · Cited by 5
“Over a six-year follow-up period, the conversion rate rises to about 80%, although some individuals may remain stable 14 – 16 .”
Zinc and Neurodegenerative Diseases
Kawahara, M., Konoha, K., Koyama, H., Ohkawara, S., & Sadakane, Y. (2013) · InTech eBooks · doi:10.5772/54489 · Cited by 2
“Al‐ though the physiological role of ZnT-3 and vesicular zinc remain elusive, recent studies have suggested the implication of ZnT-3 or other Zn transporters in the pathogenesis of AD and other neurodegenerative diseases [14].”
BackgroundElectroretinographic Recordings from the Isolated and Superfused Murine Retina
Alnawaiseh, M., Albanna, W., Banat, M., Abumuaileq, R., Jurgen, H., & Toni, S. (2011) · InTech eBooks · doi:10.5772/21675 · Cited by 1
“The disturbance of their homoeostasis may be responsible for several neurological diseases as for example Morbus Alzheimer [25;26].”
BackgroundBinding of Cu2+ to Aβ1-29 causes aggregation and toxicity in SH-SY5Y cells
Taniguchi, M., Saito, M., Kuga, T., & Yamagishi, N. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.11.031 · Cited by 2
Zinc ion fluxes on the pathway to mammalian sperm fertilization competency
Kerns, K. C. (2019) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/75025 · Cited by 2
ALTERATIONS OF ZINC TRANSPORTERS IN ALZHEIMER'S DISEASE
Lyubartseva, G. (2009) · UKnowledge (University of Kentucky)
DEVELOPMENT OF FUNCTIONAL PROTEOMICS APPROACHES FOR STUDYING RETROGRADE TRANSPORT
Shi, G. (2011) · HAL · Cited by 1
Shigemizu, D., Akiyama, S., Higaki, S., Sugimoto, T., Sakurai, T., Boroevich, K. A., Sharma, A., Tsunoda, T., Ochiya, T., Niida, S., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13219377
Xu, J., Zhou, F., Fu, Y., Sun, Z., Sun, Y., Zhu, X., Pan, S., Jiang, K., & Tong, Z. (2026) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0000000000000430
Metadata
- Authors
- Lovell, M. A.
- Affiliations
- University of Kentucky (US)
- Corresponding author
- Lovell, Mark A.
- ORCID
- Lovell, Mark A.
- Venue
- Journal of Alzheimer s Disease
- Publisher
- SAGE Publications
- Published
- 2009-03-09
- Volume
- 16
- Issue
- 3
- Pages
- 471-483
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC2881701
- OpenAlex
- W2138475095
- Cited by
- 87
- References
- 199
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 2 · 2023: 5 · 2022: 7 · 2021: 4 · 2020: 9 · 2019: 2 · 2018: 3 · 2017: 5 · 2016: 4 · 2015: 4 · 2014: 2 · 2013: 11 · 2012: 10
- FWCI
- 5.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (P30AG028383, P01AG005119, R01AG016269)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- zinc
- MeSH terms
- Aged, Alzheimer Disease, Carrier Proteins, Cognition Disorders, Humans, Zinc, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.